Hong Kong Stock Market anomaly | Veridispol-B (09887.HK) rose more than 5% in the afternoon, LBL-024 first patient with melanoma in Phase Ib/II clinical trial entered the group.

According to the Securities Times Finance app, Vitasoy International Holdings Ltd-B (09887.HK) rose more than 5% in the afternoon, with a 4.84% increase at the time of publication, reaching HK$65, with a trading volume of HK$221.07 million.